ImageneBio (IMA) Other Operating Expenses (2024 - 2025)
ImageneBio (IMA) posted Other Operating Expenses of -$2.8 million for Q3 2025, down 98.54% sequentially from -$1.4 million in Q1 2025, and down 586.51% YoY from $585604.3 in Q3 2024.
ImageneBio (IMA) Other Operating Expenses (2024 - 2025) Analysis & Trends
ImageneBio has reported Other Operating Expenses for 2 years, with the latest figure at -$2.8 million in Q3 2025.
- Quarterly Other Operating Expenses fell 586.51% year-over-year to -$2.8 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$4.3 million (down 2590.7% YoY) and the FY2024 annual result came in at $2.6 million, changed N/A from the prior year.
- Other Operating Expenses retreated to -$2.8 million in Q3 2025 per IMA's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $5.0 million in Q4 2024 and troughed at -$4.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.85 Mn |
| Mar 31, 2025 | -1.44 Mn |
| Dec 31, 2024 | 4.96 Mn |
| Sep 30, 2024 | -415,000.00 |
| Mar 31, 2024 | -4.37 Mn |